UV damage mapping reveals different impacts of yeast XPD mutations on global genomic and transcription-coupled DNA repair
Two subpathways of Nucleotide Excision Repair (NER), global genomic (GG-NER) and transcription-coupled NER (TC-NER), remove bulky DNA lesions such as cyclobutane pyrimidine dimers (CPDs). Xeroderma pigmentosum protein D (XPD) is a DNA helicase subunit within the transcription factor IIH (TFIIH) complex that is important for DNA unwinding and damage verification during NER. Germline mutations in XPD can not only cause the cancer-prone disease Xeroderma Pigmentosum (XP), but also a combination of XP with Cockayne Syndrome (CS), a syndrome characterized by neurodegeneration and premature aging. While XP and XP/CS mutations in XPD disrupt NER, their specific effects on the NER subpathways are less well understood. In this study, we introduced two pairs of XP and XP/CS mutations into the yeast RAD3 gene, a homolog of human XPD. Our data indicates that yeast XP/CS mutants are more sensitive to UV radiation and have reduced NER capacity relative to the XP mutants. Using a damage mapping method named CPD sequencing (CPD-seq 2.0), we found that the XP/CS mutations abrogated repair by both GG-NER and TC-NER, while XP mutations impaired GG-NER but retained significant TC-NER activity. Consistent with these results, XPD mutant human cell lines established from individuals with XP/CS were sensitivity to Illudin S, an agent that induces damage repaired by TC-NER. Thus, we conclude that XP/CS mutations not only cause a more severe overall NER defect than XP mutations, but specifically disrupt the TC-NER subpathway, with this defect likely underlying the Cockayne Syndrome symptoms.
- Journal
- The Journal of biological chemistry(2026 Aug)
- Authors
- 3名
- Type
- Journal Article